Leo International Group

Leo International Group (LIPH AG) is a global healthcare holding company and investment platform specializing in AI-driven precision health. The company integrates a diverse portfolio of assets spanning biotechnology, medical technology, and healthcare services to create a synchronised "Precision Health Engine." Its ecosystem includes companies focused on AI diagnostics (amiko AI), molecular pathology (Pathomics Health), and longevity-focused nutraceuticals (Renhe Biotech). Headquartered in Singapore and listed on the Frankfurt Stock Exchange, the group aims to transform healthcare from reactive treatment into predictive, personalized, and continuous care through strategic acquisitions and cross-portfolio synergies.